Labs / ADME, DMPK & toxicology

Tubulis
Planegg-Martinsried, Germany · tubulis.com
GLP · GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Tubulis develops next-generation antibody-drug conjugates and related conjugation technologies for oncology. The company is based in Munich, with additional locations in Cambridge, Massachusetts, and Epalinges, Switzerland, and its programs include clinical-stage candidates for solid tumors and hematologic tumors.
They take quote requests by email.
What they offer
ADC technology platforms
Develops platform technologies for antibody-drug conjugates, including P5 Conjugation, Tubutecan, and Alco5.
ADC candidate development
Develops antibody-drug conjugate candidates such as TUB-040 and TUB-030 for oncology indications.
Protein-drug conjugate expertise
Offers its conjugation technology and expertise for uniquely matched protein-drug conjugates.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Cell therapy
- Species and models
- preclinical models, solid tumors, hematologic tumors
- Therapeutic areas
- oncology, ovarian cancer, non-small cell lung cancer, solid tumors, hematologic tumors
- Sites
- Planegg-Martinsried, Germany · Cambridge, United States · Epalinges, Switzerland
- Quality
- GxP (quality management and compliance management)
- Address
- 1066 Epalinges The Tubulis Team Dr. Dominik Schumacher CEO View BIO CV of Dr. Dominik Schumacher Dominik
- Founded
- 2015
Public records
- Ownership
- Tubulis GmbH · DE GLEIF
Similar labs. Evotec, Bambusa Therapeutics, ProtaGene, Sai Life
Found in a contract services directory. Listing built from tubulis.com. Work here? Claim this listing.